Topical Tranexamic Acid After Wound Incision in Acute Thoracolumbar Burst Fracture Surgery .
The influence of topical use of tranexamic acid in reducing blood loss on early operation for thoracolumbar burst fracture: a randomized double-blinded controlled study
Eur Spine J. 2021 Oct;30(10): 3074-3080.Ninety-three patients with acute thoracolumbar burst fractures scheduled for an open decompression, fracture reduction and internal fixation procedure were randomized to receive topical tranexamic acid (n=46) or normal saline (n=47) after wound incision for the reduction of blood loss. Outcomes of interest included blood loss (intra-operative, post-operative, total, hidden), operative time, hemoglobin levels, transfusion rate, ambulation time, drainage tube removal time, and length of stay. Blood loss was assessed up to 72 hours post-operation. Results revealed that topical tranexamic acid significantly reduced blood loss (intra-operative; post-operative; total), operative time, hemoglobin levels on post-operative day 1, transfusion rate, ambulation time, drainage removal time, and length of stay compared to control.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics